In addition, exoPD-L1 presence in the plasma samples of 31 metastatic GC patients was negatively correlated with the CD4+ T cell count, CD8+ T-cell count and granzyme B, suggesting that exoPD-L1 was linked to the immunosuppressive status of GC patients. The gene discussed is CD8A; the disease is gastric cancer.